(Q54977319)
Statements
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial. (English)
Hagop Kantarjian
1 reference
Giovanni Martinelli
1 reference
Jorge Cortes
1 reference
Hartmut Döhner
1 reference
Hervé Dombret
1 reference
Elihu Estey
Stephen Strickland
Mark Levis
Jessica K Altman
Philippe Rousselot
Eunice S Wang
Tibor Kovacsovics
Alexander E Perl
Guy Gammon
Denise Trone
Nigel Russell
Björn Steffen
Claudia D Baldus
Alan Burnett
Alwin Krämer
Neil P Shah
Catherine C Smith
Deborah Lazzaretto
30 May 2018